Evidence map›Paper›PMID 37637841›Full record

ArticleFood science and biotechnology2023

Wheat sprouts (

BoYoon Chang, JinHye Bae, SeungBeom Yun, YongDuk Kim, SeongJin Park, SungYeon Kim

Open access · hybridAbstract read
In one paragraph

Article in Food science and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

BoYoon ChangInstitute of Pharmaceutical Research and Development, College of Pharmacy, Wonkwang University, Iksan, 54538 Jeonbuk Republic of Korea.
JinHye BaeInstitute of Pharmaceutical Research and Development, College of Pharmacy, Wonkwang University, Iksan, 54538 Jeonbuk Republic of Korea.
SeungBeom YunR&D Center, BTC Corporation, #703, Technology Development Center, Gyeongi Technopark, 705, Haean-ro, Sangnok-gu, Ansan-si, 15588 Gyeonggi-do Republic of Korea.
YongDuk KimR&D Center, BTC Corporation, #703, Technology Development Center, Gyeongi Technopark, 705, Haean-ro, Sangnok-gu, Ansan-si, 15588 Gyeonggi-do Republic of Korea.
SeongJin ParkReputer Co., 401, 111-18, Wonjangdong-gil, Deokjin-gu, Jeonju-si, 54810 Jeollabuk-do Republic of Korea.
SungYeon KimInstitute of Pharmaceutical Research and Development, College of Pharmacy, Wonkwang University, Iksan, 54538 Jeonbuk Republic of Korea.ORCID 0000-0003-4912-2554
Wonkwang University · KRPohang TechnoPark (South Korea) · KRJeonnam Bioindustry Foundation · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wheat is cultivated worldwide and is the most widely distributed food crop. Wheat is a staple crop in many countries. However, the effects of various cultivation methods on the efficacy of wheat sprouts have not been determined. This study investigated wheat sprouts obtained using a standardized smart farm system (WS-S) to improve the effects of non-alcoholic fatty liver disease (NAFLD) and molecular mechanism. Wheat sprouts significantly attenuated the accumulation of lipid droplets in FFA-induced HepG2 cells through AMPK pathway activity. In vivo experiments showed that WS-S significantly lowered body weight gain and decreased adipose tissue, lipid, aspartate transaminase, and alanine aminotransferase levels in HFD/F-treated mice. Furthermore, WS-S stimulated the phosphorylation of ACC and peroxisome proliferator-activated receptor alpha via the AMPK pathway and inhibited SREBP-1/FAS signaling to inhibit de novo adipogenesis and increase fatty acid oxidation. These results suggest that WS-S ameliorates NAFLD by regulating fatty acid metabolism via the AMPK pathway.

Indexed as

AMPKHFDNAFLDSmart farmTriticum aestivumWheat sproutWS-S

Identifiers

PMID37637841
PMCPMC10449750
OpenAlexW4365813814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.